Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Paibel I. Aguayo-Hiraldo

Title(s)Associate Professor of Clinical Pediatrics
SchoolKeck School of Medicine of Usc
Address4640 West Sunset Blvd
Off Campus
Los Angeles CA 90027
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD. Blood Adv. 2025 08 15. Akahoshi Y, Portelli J, Katsivelos N, Louloudis IE, Aguayo-Hiraldo PI, Ayuk FA, Chanswangphuwana C, Choe HK, Eder M, Etra AM, Hexner EO, Kitko CL, Kraus S, Merli P, Olson TS, Pasic I, Qayed M, Reshef R, Schechter-Finkelstein T, Marx J, Ullrich E, Vasova I, Weber D, Wölfl M, Zeiser R, Baez J, Eng GW, Gleich S, Kowalyk SM, Morales G, Spyrou N, Young R, DeFilipp Z, Hogan WJ, Nakamura R, Levine JE, Ferrara JLM. PMID: 40815797.
      View in: PubMed   Mentions:    Fields:    
    2. A reduced-toxicity myeloablative conditioning approach for hematopoietic cell transplant in juvenile myelomonocytic leukemia. Front Oncol. 2025; 15:1541192. Elsabagh E, Gallant R, Goldberg L, Sharma A, Martin PL, Driscoll TA, Bauchat A, Kurtzberg J, Spencer L, Aguayo-Hiraldo PI, Kapoor N, Mahadeo KM, Abdel-Azim H. PMID: 40530013; PMCID: PMC12170293.
      View in: PubMed   Mentions:
    3. High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation. Transplant Cell Ther. 2025 Jun; 31(6):384.e1-384.e15. Dvorak CC, Cho S, Salinas Cisneros G, Higham CS, Chu J, Winestone LE, Temple WC, Kharbanda S, Shimano KA, Avagyan S, Pauerstein PT, Huang JN, Cheng G, Lalefar N, Aguayo-Hiraldo P, Keizer RJ, Pulsipher MA, Long-Boyle JR. PMID: 40185404.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Achievement of durable remission of relapsed/refractory acute myeloid leukemia in a child using venetoclax monotherapy. Leuk Lymphoma. 2025 Jul; 66(7):1333-1337. Ferreira JE, Wang CP, Aguayo-Hiraldo P, Raca G, Parekh C, Freyer DR, Kovach AE. PMID: 40129388.
      View in: PubMed   Mentions:    Fields:    
    5. Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation. Transplant Cell Ther. 2025 Jun; 31(6):347.e1-347.e17. Dávila Saldaña BJ, Schultz KR, Ramgopal A, Boiko JR, Beebe K, Carpenter PA, Chan SS, Paczesny S, Aguayo-Hiraldo P, Cuvelier GDE, Rotz SJ, Duncan CN, Williams KM. PMID: 39855565; PMCID: PMC12146074.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group. Transplant Cell Ther. 2025 Jan; 31(1):10.e1-10.e9. Katsivelos N, Spyrou N, Weber D, Vasova I, Ayuk F, Choe H, Hogan W, DeFilipp Z, Qayed M, Etra AM, Sandhu K, Kraus S, Olson T, Hexner E, Aguayo-Hiraldo P, Reshef R, Ullrich E, Schechter T, Kitko C, Chanswangphuwana C, Merli P, Akahoshi Y, Baez J, Eng G, Beheshti R, Kowalyk S, Morales G, Louloudis IE, Young R, Holler E, Nakamura R, Ferrara JLM, Levine JE. PMID: 39667999; PMCID: PMC11735289.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT. Bone Marrow Transplant. 2025 Mar; 60(3):406-411. Merli P, Jodele S, Cook E, Myers KC, Lane A, Ryhänen S, Cefalo MP, Quagliarella F, Davies SM, Teusink-Cross A, Aguayo-Hiraldo P, Alexander JL, Szabolcs P, Kohorst M, Corsetti T, Locatelli F, Sabulski A. PMID: 39627345.
      View in: PubMed   Mentions:    Fields:    
    8. Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients. Transplant Cell Ther. 2024 Nov; 30(11):1061.e1-1061.e10. Rios CAO, Qayed M, Etra AM, Reshef R, Newcomb R, Yuhasz N, Hexner EO, Aguayo-Hiraldo P, Merli P, Hogan WJ, Weber D, Kitko CL, Ayuk F, Eder M, Grupp SA, Kraus S, Sandhu K, Ullrich E, Vasova I, Wölfl M, Baez J, Beheshti R, Eng G, Gleich S, Katsivelos N, Kowalyk S, Louloudis IE, Morales G, Spyrou N, Young R, Nakamura R, Levine JE, Ferrara JLM, Akahoshi Y. PMID: 39222793; PMCID: PMC11540730.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. Blood. 2024 08 29; 144(9):1010-1021. Akahoshi Y, Spyrou N, Weber D, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, Eder M, Etra AM, Grupp SA, Hexner EO, Hogan WJ, Kitko CL, Kraus S, Al Malki MM, Merli P, Qayed M, Reshef R, Schechter T, Ullrich E, Vasova I, Wölfl M, Zeiser R, Baez J, Beheshti R, Eng G, Gleich S, Katsivelos N, Kowalyk S, Morales G, Young R, Chen YB, Nakamura R, Levine JE, Ferrara JLM. PMID: 38968143; PMCID: PMC11830971.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. COVID-19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T-cells. Int J Cancer. 2024 Dec 15; 155(12):2190-2200. Parker RS, Le J, Villa M, Luong A, Lin TY, Lee Y, Doan A, Aguayo-Hiraldo P, Pannaraj PS, Yoon SJ, Wallace WD, Armstrong A, O'Gorman MR, Bard JD, Parekh C. PMID: 39005114; PMCID: PMC11499007.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    11. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD. Blood Adv. 2024 06 25; 8(12):3284-3292. Etra A, El Jurdi N, Katsivelos N, Kwon D, Gergoudis S, Morales G, Spyrou N, Kowalyk S, Aguayo-Hiraldo P, Akahoshi Y, Ayuk F, Baez J, Betts BC, Chanswangphuwana C, Chen YB, Choe H, DeFilipp Z, Gleich S, Hexner E, Hogan WJ, Holler E, Kitko CL, Kraus S, Al Malki M, MacMillan M, Pawarode A, Quagliarella F, Qayed M, Reshef R, Schechter T, Vasova I, Weisdorf D, Wölfl M, Young R, Nakamura R, Ferrara JLM, Levine JE, Holtan S. PMID: 38640195; PMCID: PMC11226972.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. A de novo germline RUNX1 variant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndrome. Leuk Lymphoma. 2024 Sep; 65(9):1357-1361. Wang CP, Ferreira JE, Placek A, Aguayo-Hiraldo P, Raca G, Wood BL, Miller KP, Coates T, Freyer DR, Kovach AE. PMID: 38733629.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. Blood Adv. 2024 04 23; 8(8):2047-2057. Akahoshi Y, Spyrou N, Hoepting M, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, Choe HK, Eder M, Etra AM, Grupp SA, Hexner EO, Hogan WJ, Kitko CL, Kraus S, Al Malki MM, Merli P, Qayed M, Reshef R, Schechter T, Ullrich E, Vasova I, Wölfl M, Zeiser R, Baez J, Beheshti R, Eng G, Gleich S, Kasikis S, Katsivelos N, Kowalyk S, Morales G, Young R, DeFilipp Z, Ferrara JLM, Levine JE, Nakamura R. PMID: 38324721; PMCID: PMC11103178.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. Nat Commun. 2024 Apr 18; 15(1):3258. Keller MD, Hanley PJ, Chi YY, Aguayo-Hiraldo P, Dvorak CC, Verneris MR, Kohn DB, Pai SY, Dávila Saldaña BJ, Hanisch B, Quigg TC, Adams RH, Dahlberg A, Chandrakasan S, Hasan H, Malvar J, Jensen-Wachspress MA, Lazarski CA, Sani G, Idso JM, Lang H, Chansky P, McCann CD, Tanna J, Abraham AA, Webb JL, Shibli A, Keating AK, Satwani P, Muranski P, Hall E, Eckrich MJ, Shereck E, Miller H, Mamcarz E, Agarwal R, De Oliveira SN, Vander Lugt MT, Ebens CL, Aquino VM, Bednarski JJ, Chu J, Parikh S, Whangbo J, Lionakis M, Zambidis ET, Gourdine E, Bollard CM, Pulsipher MA. PMID: 38637498; PMCID: PMC11026387.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    15. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD. Transplant Cell Ther. 2024 06; 30(6):603.e1-603.e11. Qayed M, Kapoor U, Gillespie S, Westbrook A, Aguayo-Hiraldo P, Ayuk FA, Aziz M, Baez J, Choe H, DeFilipp Z, Etra A, Grupp SA, Hexner E, Holler E, Hogan WJ, Kowalyk S, Merli P, Morales G, Nakamura R, Pulsipher MA, Schechter T, Shah J, Spyrou N, Srinagesh HK, Wölfl M, Yanik G, Young R, Kitko CL, Ferrara JLM, Levine JE. PMID: 38548227; PMCID: PMC11139591.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA. Blood. 2024 03 21; 143(12):1112-1123. Jodele S, Dandoy CE, Aguayo-Hiraldo P, Lane A, Teusink-Cross A, Sabulski A, Mizuno K, Laskin BL, Freedman J, Davies SM. PMID: 37946262; PMCID: PMC10972707.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    17. Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy. Transplant Cell Ther. 2024 05; 30(5):475-487. Adams C, Keller M, Michlitsch JG, Aguayo-Hiraldo P, Chen K, Hossain MZ, Davis A, Park JR, Verneris MR, Gardner RA. PMID: 38447751; PMCID: PMC11182654.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. A Day 14 Endpoint for Acute GVHD Clinical Trials. Transplant Cell Ther. 2024 Apr; 30(4):421-432. Spyrou N, Akahoshi Y, Kowalyk S, Morales G, Beheshti R, Aguayo-Hiraldo P, Al Malki MM, Ayuk F, Bader P, Baez J, Capellini A, Choe H, DeFilipp Z, Eder M, Eng G, Etra A, Gleich S, Grupp SA, Hexner E, Hoepting M, Hogan WJ, Kasikis S, Katsivelos N, Khan A, Kitko CL, Kraus S, Kwon D, Merli P, Portelli J, Qayed M, Reshef R, Schechter T, Vasova I, Wölfl M, Wudhikarn K, Young R, Holler E, Chen YB, Nakamura R, Levine JE, Ferrara JLM. PMID: 38320730; PMCID: PMC11009039.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. The utility of biomarkers in acute GVHD prognostication. Blood Adv. 2023 09 12; 7(17):5152-5155. Spyrou N, Akahoshi Y, Ayuk F, Holler E, Choe H, Etra A, Hogan WJ, Rösler W, Hexner E, DeFilipp Z, Reshef R, Chanswangphuwana C, Qayed M, Kraus S, Eder M, Javorniczky NR, Grupp SA, Kitko CL, Merli P, Aguayo-Hiraldo P, Wölfl M, Baez J, Beheshti R, Eng G, Gleich S, Katsivelos N, Khan A, Kowalyk S, Morales G, Young R, Nakamura R, Chen YB, Levine JE, Ferrara JLM. PMID: 37142257; PMCID: PMC10480526.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    20. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD. Blood Adv. 2023 08 22; 7(16):4479-4491. Akahoshi Y, Spyrou N, Hogan WJ, Ayuk F, DeFilipp Z, Weber D, Choe HK, Hexner EO, Rösler W, Etra AM, Sandhu K, Yanik GA, Chanswangphuwana C, Kitko CL, Reshef R, Kraus S, Wölfl M, Eder M, Bertrand H, Qayed M, Merli P, Grupp SA, Aguayo-Hiraldo P, Schechter T, Ullrich E, Baez J, Beheshti R, Gleich S, Kowalyk S, Morales G, Young R, Kwon D, Nakamura R, Levine JE, Ferrara JLM, Chen YB. PMID: 37315175; PMCID: PMC10440469.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    21. Clinical Features and Risk Factors Associated With Multisystem Inflammatory Syndrome in Children With Cancer and COVID-19. JAMA Oncol. 2023 08 01; 9(8):1108-1112. Martin SD, Davis ES, Dai C, Boal LH, Araya B, Brackett J, Dickens D, Kahn A, Martinez I, Sharma A, Schwalm C, Aguayo-Hiraldo P, Bhatia S, Levine JM, Johnston EE, Wolfson JA, Pediatric Oncology COVID-19 Case Consortium. PMID: 37166782; PMCID: PMC10176181.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    22. Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival. Blood Adv. 2023 05 09; 7(9):1823-1830. Martinez C, Aguayo-Hiraldo P, Chaimowitz N, Forbes L, Rider N, Nicholas S, Seeborg F, Chinen J, Chinn I, Davis C, Roseblatt H, Noroski L, Omer B, John T, Yassine K, Naik S, Craddock J, Bhar S, Allen C, Ahmed N, Sasa G, Steffin D, Doherty E, George A, Salem B, Friend B, Hegde M, Brenner MK, Heslop HE, Leen A, Peña A, Wu M, Hanson IC, Krance RA. PMID: 36453638; PMCID: PMC10165184.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    23. Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients. Transplant Cell Ther. 2023 06; 29(6):356.e1-356.e7. Hall AG, Winestone LE, Sullivan EM, Wu Q, Lamble AJ, Walters MC, Aguayo-Hiraldo P, Baez Conde L, Coker TR, Dornsife D, Keating AK, Merino DM, Ramsey B, Park JR, Agrawal AK. PMID: 36966871; PMCID: PMC10247402.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    24. SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report. J Immunother Cancer. 2023 01; 11(1). McNerney KO, Richards RM, Aguayo-Hiraldo P, Calkoen FG, Talano JA, Moskop A, Balduzzi A, Krajewski J, Dave H, Vatsayan A, Callahan C, Liu H, Li Y, Davis KL, Maude SL. PMID: 36707090; PMCID: PMC9884906.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    25. COVID-19 outcomes in children, adolescents and young adults with cancer. Int J Cancer. 2022 Dec 01; 151(11):1913-1924. Parker RS, Le J, Doan A, Aguayo-Hiraldo P, Pannaraj PS, Rushing T, Malvar J, O'Gorman MR, Dien Bard J, Parekh C. PMID: 35793239; PMCID: PMC9350252.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    26. Ultra-High Dose Vitamin D in Pediatric Hematopoietic Stem Cell Transplantation: A Nonrandomized Controlled Trial. Transplant Cell Ther. 2021 12; 27(12):1001.e1-1001.e9. Bhandari R, Aguayo-Hiraldo P, Malvar J, Cheng K, Sacapano A, Abdel-Azim H, Chi YY, Wallace G, Asgharzadeh S, Jodele S, Orgel E. PMID: 34500127.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease. Transplant Cell Ther. 2021 12; 27(12):988.e1-988.e7. Zewde MG, Morales G, Gandhi I, Özbek U, Aguayo-Hiraldo P, Ayuk F, Baez J, Chanswangphuwana C, Choe H, DeFilipp Z, Etra A, Grupp S, Hexner EO, Hogan W, Javorniczky NR, Kasikis S, Kitko CL, Kowalyk S, Meedt E, Merli P, Nakamura R, Qayed M, Reshef R, Rösler W, Schechter T, Weber D, Wölfl M, Yanik G, Young R, Levine JE, Ferrara JLM, Chen YB. PMID: 34474163; PMCID: PMC8671218.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    28. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series. EBioMedicine. 2021 May; 67:103355. Truong TT, Ryutov A, Pandey U, Yee R, Goldberg L, Bhojwani D, Aguayo-Hiraldo P, Pinsky BA, Pekosz A, Shen L, Boyd SD, Wirz OF, Röltgen K, Bootwalla M, Maglinte DT, Ostrow D, Ruble D, Han JH, Biegel JA, Li M, Huang C, Sahoo MK, Pannaraj PS, O'Gorman M, Judkins AR, Gai X, Dien Bard J. PMID: 33915337; PMCID: PMC8072072.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    29. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv. 2021 Mar 02. Truong TT, Ryutov A, Pandey U, Yee R, Goldberg L, Bhojwani D, Aguayo-Hiraldo P, Pinsky BA, Pekosz A, Shen L, Boyd SD, Wirz OF, Röltgen K, Bootwalla M, Maglinte DT, Ostrow D, Ruble D, Han JH, Biegel JA, Li M, Huang C, Sahoo MK, Pannaraj PS, O'Gorman M, Judkins AR, Gai X, Bard JD. PMID: 33688673; PMCID: PMC7941650.
      View in: PubMed   Mentions:
    30. Toward Functional Immune Monitoring in Allogeneic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant. 2020 05; 26(5):911-919. Naik S, Vasileiou S, Aguayo-Hiraldo P, Mukhi S, Sasa G, Martinez C, Krance RA, Gottschalk S, Leen A. PMID: 31927102.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    31. Association between Vitamin D and Risk for Early and Late Post-Transplant Complications. Biol Blood Marrow Transplant. 2020 02; 26(2):343-350. Bhandari R, Malvar J, Sacapano A, Aguayo-Hiraldo P, Jodele S, Orgel E. PMID: 31654787.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients. Am J Transplant. 2018 09; 18(9):2238-2249. Arasaratnam RJ, Tzannou I, Gray T, Aguayo-Hiraldo PI, Kuvalekar M, Naik S, Gaikwad A, Liu H, Miloh T, Vera JF, Himes RW, Munoz FM, Leen AM. PMID: 29900673; PMCID: PMC6117219.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    33. Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy. J Infect Dis. 2017 09 15; 216(6):678-687. Tzannou I, Nicholas SK, Lulla P, Aguayo-Hiraldo PI, Misra A, Martinez CA, Machado AA, Orange JS, Piedra PA, Vera JF, Leen AM. PMID: 28934427; PMCID: PMC5853664.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    34. Characterizing the Cellular Immune Response to Parainfluenza Virus 3. J Infect Dis. 2017 07 15; 216(2):153-161. Aguayo-Hiraldo PI, Arasaratnam RJ, Tzannou I, Kuvalekar M, Lulla P, Naik S, Martinez CA, Piedra PA, Vera JF, Leen AM. PMID: 28472480; PMCID: PMC5853958.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    35. Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease. Bol Med Hosp Infant Mex. 2016 Jan - Feb; 73(1):31-40. Aguayo-Hiraldo P, Arasaratnam R, Rouce RH. PMID: 29421230.
      View in: PubMed   Mentions:    Fields:    
    Paibel's Networks
    Concepts (120)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (27)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.